Placing the search for a cure for HIV/AIDS firmly at the center of its research efforts, amfAR has launched the amfAR Research Consortium on HIV Eradication (ARCHE). This new grant program will support collaborative teams of biomedical researchers exploring strategies for eradicating HIV infection. 

"amfAR has a long and successful history of bringing people together to take on the big challenges of HIV/AIDS," says Dr. Rowena Johnston, amfAR’s vice president and director of research. "We’re tremendously excited by this consortium. And we’re confident that this collaborative approach will create a synergy that produces results that exceed what can be generated in individual laboratories." 

About ARCHE (Second year)

amfAR Consortium Helps Lead Efforts for HIV/AIDS Cure 

About ARCHE (Inaugural year)

amfAR Launches Cure Consortium 

ARCHE Research Teams and Their Projects 

News and Features

amfAR Symposium Looks to Holy Grail of AIDS Research 

amfAR Ramps Up Investment in HIV Cure Research 

ARCHE Researchers Prove the Value of Collaboration 

The Search for a Cure—Why Now? 

Charting a Path to a Cure 

amfAR Consortium To Speed Search for HIV/AIDS Cure 

The Search for a Cure: An Enduring Commitment 

Dr. Martin Markowitz at a November 2011 amfAR symposium

“While others have doubted, amfAR has always believed a cure for AIDS to be possible.” 
 —Dr. Martin Markowitz, Aaron Diamond AIDS Research Center, New York City